A simple method for assessing intestinal inflammation in Crohn's disease
J Tibble, K Teahon, B Thjodleifsson, A Roseth, G Sigthorsson, S Bridger, R Foster, R Sherwood, M Fagerhol, I Bjarnason, J Tibble, K Teahon, B Thjodleifsson, A Roseth, G Sigthorsson, S Bridger, R Foster, R Sherwood, M Fagerhol, I Bjarnason
Abstract
Background and aims: Assessing the presence and degree of intestinal inflammation objectively, simply, and reliably is a significant problem in gastroenterology. We assessed faecal excretion of calprotectin, a stable neutrophil specific marker, as an index of intestinal inflammation and its potential use as a screening test to discriminate between patients with Crohn's disease and those with irritable bowel syndrome.
Methods: The validity of faecal calprotectin as a marker of intestinal inflammation was assessed in 22 patients with Crohn's disease (35 studies) by comparing faecal excretions and concentrations using four day faecal excretion of (111)indium white cells. A cross sectional study assessed the sensitivity of faecal calprotectin concentration for the detection of established Crohn's disease (n=116). A prospective study assessed the value of faecal calprotectin in discriminating between patients with Crohn's disease and irritable bowel syndrome in 220 patients referred to a gastroenterology clinic.
Results: Four day faecal excretion of (111)indium (median 8.7%; 95% confidence interval (CI) 7-17%; normal <1.0%) correlated significantly (p<0.0001) with daily (median ranged from 39 to 47 mg; normal <3 mg; r=0.76-0.82) and four day faecal calprotectin excretion (median 101 mg; 95% CI 45-168 mg; normal <11 mg; r=0.80) and single stool calprotectin concentrations (median 118 mg/l; 95% CI 36-175 mg/l; normal <10 mg/l; r=0.70) in patients with Crohn's disease. The cross sectional study showed a sensitivity of 96% for calprotectin in discriminating between normal subjects (2 mg/l; 95% CI 2-3 mg/l) and those with Crohn's disease (91 mg/l; 95% CI 59-105 mg/l). With a cut off point of 30 mg/l faecal calprotectin has 100% sensitivity and 97% specificity in discriminating between active Crohn's disease and irritable bowel syndrome.
Conclusion: The calprotectin method may be a useful adjuvant for discriminating between patients with Crohn's disease and irritable bowel syndrome.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1728060/bin/991365.f1.jpg)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1728060/bin/991365.f2.jpg)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1728060/bin/991365.f3.jpg)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1728060/bin/991365.f4.jpg)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1728060/bin/991365.f5.jpg)
References
- Gastroenterology. 1976 Mar;70(3):439-44
- J Clin Gastroenterol. 1990 Dec;12(6):643-6
- Lancet. 1980 Mar 8;1(8167):514
- Lancet. 1980 Mar 29;1(8170):711
- Gastroenterology. 1991 Jul;101(1):84-9
- Lancet. 1992 Jan 11;339(8785):89-91
- Scand J Gastroenterol. 1992;27(2):139-42
- J Clin Microbiol. 1992 May;30(5):1238-42
- Scand J Gastroenterol. 1992 Sep;27(9):774-8
- Scand J Gastroenterol. 1992 Sep;27(9):793-8
- Gastroenterology. 1993 Apr;104(4):1064-71
- N Engl J Med. 1993 Jul 1;329(1):14-20
- N Engl J Med. 1993 Dec 23;329(26):1940-5
- Scand J Gastroenterol. 1993 Dec;28(12):1073-6
- Ann Clin Biochem. 1993 Nov;30 ( Pt 6):521-39
- Gut. 1994 Jan;35(1):5-7
- Gut. 1994 Sep;35(9):1244-9
- Clin Biochem. 1994 Aug;27(4):259-64
- Scand J Gastroenterol. 1995 Jan;30(1):54-60
- Gastroenterology. 1995 May;108(5):1566-81
- Scand J Gastroenterol. 1996 Apr;31(4):339-44
- AIDS. 1996 Oct;10(12):1385-91
- Gut. 1996 Oct;39(4):580-6
- Postgrad Med. 1997 Mar;101(3):215-6, 219-20, 223-6
- Digestion. 1997;58(2):176-80
- Gastroenterology. 1997 Jun;112(6):2120-37
- Dig Dis Sci. 1998 Mar;43(3):590-5
- Gastroenterology. 1993 Jun;104(6):1832-47
- Eur J Clin Invest. 1982 Aug;12(4):351-9
- Gut. 1983 Apr;24(4):293-9
- Gastroenterology. 1983 Dec;85(6):1333-9
- Gastroenterology. 1984 Feb;86(2):249-66
- Digestion. 1986;33(2):74-9
- Gastroenterology. 1986 May;90(5 Pt 1):1121-8
- Br J Radiol. 1986 Aug;59(704):773-7
- Dig Dis Sci. 1988 Nov;33(11):1383-90
- Gut. 1989 Sep;30(9):1236-40
- Gastroenterology. 1979 Oct;77(4 Pt 2):843-6
Source: PubMed